Mechanisms of immunotherapy resistance in mCRPC: identifying the enemy on the visceral metastatic battlefield

MeSH terms

• Antibodies, Monoclonal / therapeutic use*
• Bone Neoplasms / secondary
• Bone Neoplasms / therapy*
• Drug Resistance, Neoplasm*
• Humans
• Immunotherapy*
• Ipilimumab
• Liver Neoplasms / secondary
• Liver Neoplasms / therapy*
• Lung Neoplasms / secondary
• Lung Neoplasms / therapy*
• Male
• Prostatic Neoplasms, Castration-Resistant / pathology
• Prostatic Neoplasms, Castration-Resistant / therapy*
• Viscera / pathology